Home › Executives › Michel Lagarde
ML

Michel Lagarde

Chief Operating Officer at Thermo Fisher Scientific

Vertex Pharmaceuticals•Boston, Massachusetts, United States

View LinkedIn Profile
Experience30+ Years
LevelLeadership

Career Timeline

Professional employment history
  • Vertex PharmaceuticalsCurrent
    Oct 2023–Present· 2 yrs 11 mos
    • Member, BoardCurrent
      Oct 2023–Present
  • Thermo Fisher ScientificCurrent
    Aug 2017–Present· 9 yrs 1 mo
    • Chief Operating OfficerCurrent
      2022–Present
    • Executive Vice President
      Oct 2019–2022
    • President, Pharmaceutical Services
      Aug 2017–Oct 2019
  • Patheon
    May 2016–Aug 2017· 1 yr 3 mos
    • President and Chief Operating Officer
      May 2016–Aug 2017
  • SOS Children's Villages USA
    Mar 2012–Feb 2018· 5 yrs 11 mos
    • Member, Board
      Mar 2012–Feb 2018
  • JLL Partners
    2008–May 2016· 8 yrs 4 mos
    • Managing Director
      2008–May 2016
  • Philips
    1996–2008· 12 yrs
    • CEO, Domestic Appliances North America
      Aug 2006–2008
    • CFO, Domestic Appliances North America
      Apr 2004–Aug 2006
    • CFO, Philips Indonesia
      Nov 2001–Apr 2004
    • Industry Controller, Philips Hong Kong
      Mar 2000–Nov 2001
    • Corporate Finance Analyst
      1996–Mar 2000

Education

Bachelor of Business Administration - BBA

European University, Antwerp

Executive Master of Finance & Control

Maastricht University

Executive Relationship Map

Reports To
Michel Lagarde
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer

Executive Network Preview

BizKonnect has mapped this leadership network including reporting hierarchies, peer connections, and cross-functional relationships.

Verified Contact Information
Email & Direct Dial
Org Chart & Reporting Lines
Buying Committee Insights
AI-Powered Account Mapping

Skills & Expertise

20 of 20 skills
Financial AnalysisMarketing StrategyCorporate FinanceManagementBusiness PlanningPortfolio ManagementFinancial ModelingMergers & AcquisitionsValuationCorporate DevelopmentLBOEmerging MarketsInternational BusinessM&A experienceStrategyDue DiligenceBusiness StrategyFinancial ReportingPrivate EquityMergers